Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Reviews on Recent Clinical Trials
|
August 1, 2019
Yoga Protocol for Cancer Patients: A Systematic Exploration of Psychophysiological Benefits
Mara Mirandola, Miguel David Sabogal Rueda, Federica Andreis, et al.
Reviews on Recent Clinical Trials
|
April 10, 2018
Impact of a Psycho-Educational Team in early Breast Cancer Patients' Coping Strategies: The Venere Project
Federica Andreis, Fausto Meriggi, Claudio Codignola, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2024
Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
Tiziana Pressiani, Rita Balsano, Laura Giordano, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
The Oncologist
|
May 10, 2018
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program
Chiara Cremolini, Daniele Rossini, Erika Martinelli, et al.
Cancer Medicine
|
June 6, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
Letizia Procaccio, Valeria Merz, Morena Fasano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
Oncology
|
August 22, 2018
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram
Filippo Pietrantonio, Francesco Barretta, Valentina Fanotto, et al.
Cancer Medicine
|
June 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment
Guido Giordano, Michele Milella, Matteo Landriscina, et al.
Cancer Medicine
|
January 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants
Michele Milella, Giulia Orsi, Mariacristina di Marco, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Reviews on Recent Clinical Trials
|
August 1, 2019
Yoga Protocol for Cancer Patients: A Systematic Exploration of Psychophysiological Benefits
Mara Mirandola, Miguel David Sabogal Rueda, Federica Andreis, et al.
Reviews on Recent Clinical Trials
|
April 10, 2018
Impact of a Psycho-Educational Team in early Breast Cancer Patients' Coping Strategies: The Venere Project
Federica Andreis, Fausto Meriggi, Claudio Codignola, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2024
Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
Tiziana Pressiani, Rita Balsano, Laura Giordano, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
The Oncologist
|
May 10, 2018
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program
Chiara Cremolini, Daniele Rossini, Erika Martinelli, et al.
Cancer Medicine
|
June 6, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
Letizia Procaccio, Valeria Merz, Morena Fasano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
Oncology
|
August 22, 2018
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram
Filippo Pietrantonio, Francesco Barretta, Valentina Fanotto, et al.
Cancer Medicine
|
June 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment
Guido Giordano, Michele Milella, Matteo Landriscina, et al.
Cancer Medicine
|
January 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants
Michele Milella, Giulia Orsi, Mariacristina di Marco, et al.
Page
of 3